Scott D, Colquitt J, Loveman E, Royle P. The advancement of tools for automating data extraction in systematic reviews. Poster presentation. ISPOR Europe 2018
Harris P, Takeda A, Loveman E, Hartwell D. Time to full publication of studies of anti-cancer drugs for breast cancer, and the potential for publication bias. International Journal of Technology Assessment in Health Care 2010;26(1):110-6.
Oliver S, Bagnall AM, Thomas J, Shepherd J, Sowden A, White I, Dinnes J, Rees R, Colquitt J, Oliver K, and Garret Z. Randomised controlled trials for policy interventions: a review of reviews and meta-regression. Health Technology Assessment 2010;14(16).
Takeda A, Loveman E, Harris P, Hartwell D, Welch K. Time to full publication of studies of novel chemotherapy drugs for breast cancer and the potential for publication bias: a short systematic review. Health Technology Assessment 2008;12(32).
Bryant J, Loveman E, Cave C, Chase D, Milne R. Endocrinology trial design: Adverse event reporting in randomised controlled trials of recombinant human GH in GH-deficient adults. Journal of Endocrinology 2002;175:545-52.